Analysis of lujo virus cell entry using pseudotype vesicular stomatitis virus

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7317-7330

  Tani, Hideki ^a   Iha, Koichiro ^a,c   Shimojima, Masayuki ^a   Fukushi, Shuetsu ^a   Taniguchi, Satoshi ^a,c   Yoshikawa, Tomoki ^a   Kawaoka, Yoshihiro ^a   Nakasone, Naoe ^b   Ninomiya, Haruaki ^b   Saijo, Masayuki ^a   Morikawa, Shigeru ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ALPHA DYSTROGLYCAN; CARRIER PROTEIN; NIEMANN PICK C1 PROTEIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; CELL SURFACE RECEPTOR; CHOLESTEROL; MEMBRANE PROTEIN; NPC1 PROTEIN, HUMAN; SPHINGOLIPID;

ANIMAL CELL; ARENAVIRUS; ARTICLE; CELL ACTIVITY; CELL FUSION; CELL LINE; CHAPARE VIRUS; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOTYPING; VESICULAR STOMATITIS VIRUS; VIRUS ENTRY; VIRUS INFECTIVITY; ANIMAL; ARENAVIRUS INFECTION; FLUORESCENT ANTIBODY TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIROLOGY;

ANIMALS; ARENAVIRIDAE INFECTIONS; CARRIER PROTEINS; CHOLESTEROL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LUJO VIRUS; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; SPHINGOLIPIDS; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84901992355     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00512-14     Document Type: Article

References (52)

1. Bowen MD, Peters CJ, Nichol ST. 1997. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol. Phylogenet. Evol. 8:301-316. http://dx.doi.org/10.1006/mpev.1997.0436.
2. Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E, Albarino CG, Vargas J, Comer JA, Rollin PE, Ksiazek TG, Olson JG, Nichol ST. 2008. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 4:e1000047. http://dx.doi.org/10 .1371/journal.ppat.1000047.
3. McCormick JB, Fisher-Hoch SP. 2002. Lassa fever, p 75-109. In Oldstone MBA (ed), Arenaviruses I. Current topics in microbiology and immunology, vol 262. Springer, New York, NY. http://dx.doi.org/10.1007/978-3-642-56029-3_4.
4. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, Palacios G, Khristova ML, Weyer J, Swanepoel R, Egholm M, Nichol ST, Lipkin WI. 2009. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 5:e1000455. http://dx.doi.org/10.1371/journal.ppat.1000455.
5. Burri DJ, da Palma JR, Kunz S, Pasquato A. 2012. Envelope glycoprotein of arenaviruses. Viruses 4:2162-2181. http://dx.doi.org/10.3390/v4102162.
6. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081. http://dx.doi.org/10.1126 /science.282.5396.2079.
7. Rojek JM, Spiropoulou CF, Campbell KP, Kunz S. 2007. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. J. Virol. 81:5685-5695. http://dx.doi.org/10.1128/JVI.02574-06.
8. Flanagan ML, Oldenburg J, Reignier T, Holt N, Hamilton GA, Martin VK, Cannon PM. 2008. New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and-independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J. Virol. 82:938-948. http://dx.doi.org/10.1128/JVI.01397-07.
9. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H.2007. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96. http://dx.doi.org/10.1038 /nature05539.
10. Shimojima M, Kawaoka Y. 2012. Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein. J. Vet. Med. Sci. 74:1363-1366. http://dx.doi.org/10.1292/jvms.12-0176.
11. Shimojima M, Stroher U, Ebihara H, Feldmann H, Kawaoka Y. 2012. Identification of cell surface molecules involved in dystroglycanindependent Lassa virus cell entry. J. Virol. 86:2067-2078. http://dx.doi .org/10.1128/JVI.06451-11.
12. Martinez MG, Bialecki MA, Belouzard S, Cordo SM, Candurra NA, Whittaker GR. 2013. Utilization of human DC-SIGN and L-SIGN for entry and infection of host cells by the New World arenavirus, Junin virus. Biochem. Biophys. Res. Commun. 441:612-617. http://dx.doi.org/10 .1016/j.bbrc.2013.10.106.
13. Goncalves AR, Moraz ML, Pasquato A, Helenius A, Lozach PY, Kunz S.2013. Role of DC-SIGN in Lassa virus entry into human dendritic cells. J. Virol. 87:11504-11515. http://dx.doi.org/10.1128/JVI.01893-13.
14. Takikawa S, Ishii K, Aizaki H, Suzuki T, Asakura H, Matsuura Y, Miyamura T. 2000. Cell fusion activity of hepatitis C virus envelope proteins. J. Virol. 74:5066-5074. http://dx.doi.org/10.1128/JVI.74.11.5066-5074.2000.
15. Tani H, Morikawa S, Matsuura Y. 2011. Development and applications of VSV vectors based on cell tropism. Front. Microbiol. 2:272. http://dx .doi.org/10.3389/fmicb.2011.00272.
16. Saijo M, Qing T, Niikura M, Maeda A, Ikegami T, Sakai K, Prehaud C, Kurane I,MorikawaS. 2002.Immunofluorescencetechnique usingHeLacells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J. Clin. Microbiol. 40:372-375. http: //dx.doi.org/10.1128/JCM.40.2.372-375.2002.
17. Sayama Y, Demetria C, Saito M, Azul RR, Taniguchi S, Fukushi S, Yoshikawa T, Iizuka I, Mizutani T, Kurane I, Malbas FF, Jr, Lupisan S, Catbagan DP, Animas SB, Morales RG, Lopez EL, Dazo KR, Cruz MS, Olveda R, Saijo M, Oshitani H, Morikawa S. 2012. A seroepidemiologic study of Reston ebolavirus in swine in the Philippines.BMCVet. Res. 8:82. http://dx.doi.org/10.1186/1746-6148-8-82.
18. Higaki K, Ninomiya H, Sugimoto Y, Suzuki T, Taniguchi M, Niwa H, Pentchev PG, Vanier MT, Ohno K. 2001. Isolation of NPC1-deficient Chinese hamster ovary cell mutants by gene trap mutagenesis. J. Biochem. 129:875-880. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a002932.
19. Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, Owsianka A, Patel AH, Whitt MA, Matsuura Y. 2007. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J. Virol. 81:8601-8612. http://dx.doi.org/10.1128/JVI.00608-07.
20. Taniguchi S, Sayama Y, Nagata N, Ikegami T, Miranda ME, Watanabe S, Iizuka I, Fukushi S, Mizutani T, Ishii Y, Saijo M, Akashi H, Yoshikawa Y, Kyuwa S, Morikawa S. 2012. Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines. BMC Vet. Res. 8:189. http://dx.doi.org/10.1186/1746-6148-8-189.
21. Tani H, Shiokawa M, Kaname Y, Kambara H, Mori Y, Abe T, Moriishi K, Matsuura Y. 2010. Involvement of ceramide in the propagation of Japanese encephalitis virus. J. Virol. 84:2798-2807. http://dx.doi.org/10 .1128/JVI.02499-09.
22. Fukushi S, Tani H, Yoshikawa T, Saijo M, Morikawa S. 2012. Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses 4:2097-2114. http://dx.doi.org/10.3390/v4102097.
23. Ward JH, Kushner JP, Kaplan J. 1982. Transferrin receptors of human fibroblasts. Analysis of receptor properties and regulation. Biochem. J. 208:19-26.
24. Iha K. 2013. Pseudotyped vesicular stomatitis virus for analysis of entry of arenaviruses and its application to serodiagnosis of Argentine hemorrhagic fever. .Ph.D. thesis. University of Tokyo, Tokyo, Japan.
25. Spiro MJ, Spiro RG. 2000. Use of recombinant endomannosidase for evaluation of the processing of N-linked oligosaccharides of glycoproteins and their oligosaccharide-lipid precursors. Glycobiology 10:521-529. http://dx.doi.org/10.1093/glycob/10.5.521.
26. Spiro MJ, Spiro RG. 2001. Release of polymannose oligosaccharides from vesicular stomatitis virus G protein during endoplasmic reticulumassociated degradation. Glycobiology 11:803-811. http://dx.doi.org/10 .1093/glycob/11.10.803.
27. Glushakova SE, Lukashevich IS. 1989. Early events in arenavirus replication are sensitive to lysosomotropic compounds. Arch. Virol. 104:157-161. http://dx.doi.org/10.1007/BF01313817.
28. Castilla V, Palermo LM, Coto CE. 2001. Involvement of vacuolar proton ATPase in Junin virus multiplication. Arch. Virol. 146:251-263. http://dx .doi.org/10.1007/s007050170173.
29. Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, Pecheur EI, ter Meulen J, Deubel V, Bartosch B. 2009. Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J. Virol. 83:3228-3237. http://dx.doi.org/10.1128/JVI.01711-08.
30. Kunz S, Rojek JM, Kanagawa M, Spiropoulou CF, Barresi R, Campbell KP, Oldstone MB. 2005. Posttranslational modification of alphadystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J. Virol. 79:14282-14296. http: //dx.doi.org/10.1128/JVI.79.22.14282-14296.2005.
31. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340-343. http://dx.doi.org/10.1038/nature10348.
32. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, Chandran K. 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor.EMBOJ. 31:1947-1960. http://dx.doi.org/10.1038/emboj.2012.53.
33. Miller ME, Adhikary S, Kolokoltsov AA, Davey RA. 2012. Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection. J. Virol. 86:7473-7483. http://dx.doi.org/10.1128 /JVI.00136-12.
34. Lange Y, Ye J, Steck TL. 2012. Activation mobilizes the cholesterol in the late endosomes-lysosomes of Niemann Pick type C cells. PLoS One 7:e30051. http://dx.doi.org/10.1371/journal.pone.0030051.
35. Martinez MG, Cordo SM, Candurra NA. 2007. Characterization of Junin arenavirus cell entry. J. Gen. Virol. 88:1776-1784. http://dx.doi.org/10 .1099/vir.0.82808-0.
36. Liscum L, Faust JR. 1989. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J. Biol. Chem. 264:11796-11806.
37. Cenedella RJ. 2009. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 44:477-487. http://dx.doi.org/10.1007/s11745-009-3305-7.
38. Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W. 2001. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl. Acad. Sci. U. S. A. 98:12701-12705. http://dx .doi.org/10.1073/pnas.221447598.
39. Albarino CG, Bergeron E, Erickson BR, Khristova ML, Rollin PE, Nichol ST. 2009. Efficient reverse genetics generation of infectious Junin viruses differing in glycoprotein processing. J. Virol. 83:5606-5614. http: //dx.doi.org/10.1128/JVI.00276-09.
40. Eichler R, Lenz O, Garten W, Strecker T. 2006. The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C. Virol. J. 3:41. http://dx.doi.org/10.1186/1743-422X-3-41.
41. Marozin S, Altomonte J, Apfel S, Dinh PX, De Toni EN, Rizzani A, Nussler A, Kato N, Schmid RM, Pattnaik AK, Ebert O. 2012. Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125. J. Virol. 86:4844-4855. http://dx.doi.org/10.1128/JVI.06649-11.
42. Rojek JM, Campbell KP, Oldstone MB, Kunz S. 2007. Old World arenavirus infection interferes with the expression of functional alphadystroglycan in the host cell. Mol. Biol. Cell 18:4493-4507. http://dx.doi .org/10.1091/mbc.E07-04-0374.
43. Bergeron E, Chakrabarti AK, Bird BH, Dodd KA, McMullan LK, Spiropoulou CF, Nichol ST, Albarino CG. 2012. Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth. J. Virol. 86:10759-10765. http://dx.doi.org/10.1128/JVI .01144-12.
44. Abraham J, Kwong JA, Albarino CG, Lu JG, Radoshitzky SR, Salazar-Bravo J, Farzan M, Spiropoulou CF, Choe H. 2009. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog. 5:e1000358. http://dx.doi.org /10.1371/journal.ppat.1000358.
45. Suenaga T, Satoh T, Somboonthum P, Kawaguchi Y, Mori Y, Arase H.2010. Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc. Natl. Acad. Sci. U. S. A. 107:866-871. http://dx.doi.org/10.1073/pnas.0913351107.
46. Tanaka Y, Suenaga T, Matsumoto M, Seya T, Arase H. 2013. Herpesvirus 6 glycoproteins B (gB), gH, gL, and gQ are necessary and sufficient for cell-to-cell fusion. J. Virol. 87:10900-10903. http://dx.doi.org/10.1128 /JVI.01427-13.
47. Castilla V, Mersich SE. 1996. Low-pH-induced fusion of Vero cells infected with Junin virus. Arch. Virol. 141:1307-1317. http://dx.doi.org/10 .1007/BF01718832.
48. Klewitz C, Klenk HD, ter Meulen J. 2007. Amino acids from both N-terminal hydrophobic regions of the Lassa virus envelope glycoprotein GP-2 are critical for pH-dependent membrane fusion and infectivity. J. Gen. Virol. 88:2320-2328. http://dx.doi.org/10.1099/vir.0.82950-0.
49. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. U. S. A. 102:11876-11881. http://dx.doi.org/10.1073/pnas.0505577102.
50. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. http://dx.doi.org/10.1126/science.1110656.
51. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J.2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80:4174-4178. http://dx.doi.org/10.1128/JVI.80.8 .4174-4178.2006.
52. Garver WS, Heidenreich RA, Erickson RP, Thomas MA, Wilson JM.2000. Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments. J. Lipid Res. 41:673-687.